The data displays the value of the prescribed ophthalmology market in the U.S. from 2009 to 2016. In 2010, some 6.3 billion USD were spent in this area, making this therapeutic area one the top therapeutic classes in the U.S. Until 2016, dermatologicals spending increased 11 billion USD.
2009 | 5.8 |
2010 | 6.3 |
2011 | 6.8 |
2012 | 7.6 |
2013 | 8.8 |
2014 | 9.4 |
2015 | 10.7 |
2016 | 11 |